- ►annals.org JR Leclerc, WH Geerts, L Desjardins, GH … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To compare the effectiveness and safety of fixed-dose enoxaparin ... Cited by 163 - Related articles - BL Direct - All 5 versions
JA Heit, SD Berkowitz, R Bona, V Cabanas, JD … - Thrombosis and haemostasis, 1997 - cat.inist.fr We performed a double-blind, randomized clinical trial to compare the efficacy
and safety of three different subcutaneous(SC) low molecular weight heparin
doses(ardeparin sodium 25, 35, or 50 anti-XaU/kg twice daily[BID]) to ... Cited by 75 - Related articles - BL Direct - All 3 versions
CW Colwell, TE Spiro, AA Trowbridge, JWG … - Clinical orthopaedics and related research, 1995 - journals.lww.com This study was a randomized, parallel-group, open-label clinical trial comparing
the efficacy and safety of Enoxaparin, a low-molecular-weight heparin, and
unfractionated heparin to prevent deep venous thrombosis after elective ... Cited by 93 - Related articles - BL Direct - All 4 versions
R Hull, G Raskob, G Pineo, D Rosenbloom, W … - The New England journal of medicine, 1993 - nejm.highwire.org Results Among the 1207 patients with interpretable venograms, 231 of 617
patients (37.4 percent) in the warfarin group and 185 of 590 patients (31.4
percent) in the low-molecular-weight-heparin group had deep-vein thrombosis ... Cited by 313 - Related articles - BL Direct - All 6 versions
- ►ejbjs.org [PDF] P Fauno, O Suomalainen, V Rehnberg, TB … - The Journal of Bone and Joint Surgery, 1994 - JBJS The PDF of the article you requested follows this cover page. This is an
enhanced PDF from The Journal of Bone and Joint Surgery ... 1994;76:1814-1818.
J Bone Joint Surg Am. P Fauno, O Suomalainen, V Rehnberg, TB Hansen, K ... Cited by 75 - Related articles - BL Direct - All 3 versions
K Hamulyak, AW Lensing, J Van der Meer, … - Thrombosis and haemostasis, 1995 - ncbi.nlm.nih.gov OBJECTIVE: To compare efficacy, safety, and feasibility of adjusted-dose oral
anticoagulants (OAC) versus fixed-dose subcutaneous low molecular weight heparin
(LMWH) for the prevention of deep venous thrombosis (DVT) in patients who ... Cited by 77 - Related articles - BL Direct - All 2 versions
JR Leclerc, WH Geerts, L Desjardins, F Jobin, … - Thrombosis and haemostasis, 1992 - cat.inist.fr Prevention of deep vein thrombosis after major knee surgery: a randomized,
double-blind trial comparing a low molecular weight heparin fragment(enoxaparin) ... Cited by 127 - Related articles - All 2 versions
RH Fitzgerald, TE Spiro, AA Trowbridge, GA … - The Journal of Bone and Joint Surgery, 2001 - JBJS AA Trowbridge, MD Division of Hematology, Department of Internal Medicine, Scott
and White Clinic, Texas A and M University College of Medicine, 2401 South 31st
Street, Temple, TX 76508 GA Gardiner Jr., MD Department of Radiology, ... Cited by 82 - Related articles - All 3 versions
A Planes, N Vochelle, F Mazas, C Mansat, J … - Thrombosis and haemostasis, 1988 - ncbi.nlm.nih.gov A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once
daily) with standard unfractionated calcium heparin administered at a dose of
5,000 units every 8 hours in patients undergoing elective hip replacement ... Cited by 164 - Related articles
- ►ejbjs.org CW Francis, VD Pellegrini Jr, S Totterman, … - The Journal of Bone and Joint Surgery, 1997 - JBJS The effectiveness and safety of warfarin were compared with those of a
low-molecular-weight heparin (dalteparin) for the prevention of deep-vein
thrombosis after total hip arthroplasty in a prospective, randomized, multi- ... Cited by 128 - Related articles - BL Direct - All 4 versions
